MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets advanced MASH liver damage
Disease control OngoingThis early-stage study tests a new medicine called RO7790121 in 50 adults with advanced liver scarring (fibrosis) caused by MASH. The main goal is to check the drug's safety and how the body processes it. Participants must have a certain body mass index and liver stiffness level.…
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New MASH drug enters early safety testing
Disease control OngoingThis early-stage study tests a new drug called CS060304 in healthy volunteers and people with high LDL cholesterol. The main goal is to check safety and how the drug moves through the body. It is a first step toward finding a treatment for MASH, a serious liver disease.
Matched conditions: MASH
Phase: PHASE1 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated May 05, 2026 11:53 UTC